CARotid plaqUe StabilizatiOn and Regression With Evolocumab: the CARUSO Study
Latest Information Update: 06 Jul 2023
At a glance
- Drugs Evolocumab (Primary) ; Ezetimibe; HMG-CoA reductase inhibitors
- Indications Carotid artery diseases; Carotid stenosis
- Focus Therapeutic Use
- Acronyms CARUSO
- 22 Jul 2021 Planned End Date changed from 1 Mar 2022 to 31 Mar 2022.
- 22 Jul 2021 Planned primary completion date changed from 31 Jan 2022 to 31 Mar 2022.
- 01 Jul 2021 Trial design published in the Catheterization and Cardiovascular Interventions